Search

Your search keyword '"S. Boselli"' showing total 26 results

Search Constraints

Start Over You searched for: Author "S. Boselli" Remove constraint Author: "S. Boselli" Language english Remove constraint Language: english
26 results on '"S. Boselli"'

Search Results

1. FCC Physics Opportunities

2. Coronavirus disease 2019 in patients with neuroendocrine neoplasms

3. HE-LHC: The High-Energy Large Hadron Collider Future Circular Collider Conceptual Design Report Volume 4

4. Report on the Physics at the HL-LHC, and Perspectives for the HE-LHC

5. Prospects for the determination of the top-quark Yukawa coupling at future $e^+e^-$ colliders

6. Higgs decay into four charged leptons in the presence of dimension-six operators

7. Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

8. Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers.

9. Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years' multi-stakeholder dialogue on improving access in Europe via MoCA.

10. COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study.

12. Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study.

13. Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory study.

14. Molecular features and clinical outcome of lung malignancies in very young people.

15. Breast phyllodes tumor: a review of literature and a single center retrospective series analysis.

16. Hepatic intra-arterial chemotherapy in patients with advanced primary liver tumours.

17. Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study.

18. Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors.

19. Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination.

20. Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer.

21. Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer.

22. Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents.

23. Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma.

24. A 15-min premedication for 1-h paclitaxel infusion: optimizing patients' care.

25. First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer.

26. A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients.

Catalog

Books, media, physical & digital resources